Westwood, NJ, United States of America

Darrell Yamashiro

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Darrell Yamashiro. Retrieved from https://idiyas.com/inventor/darrell-yamashiro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Darrell Yamashiro: Innovator in Tumor Regression Methods

Introduction

Darrell Yamashiro is a notable inventor based in Westwood, NJ (US). He has made significant contributions to the field of oncology through his innovative methods for tumor regression. His work focuses on utilizing vascular endothelial growth factor (VEGF) inhibitors to combat cancer effectively.

Latest Patents

Yamashiro holds a patent for a method of tumor regression with VEGF inhibitors. This patent describes methods of regressing or inhibiting a tumor in a subject by administering an agent capable of blocking, inhibiting, or ameliorating VEGF-mediated activity. The method results in a reduction of tumor size and inhibition of tumor metastases, making it particularly useful for patients suffering from bulky, metastatic cancers. He has 1 patent to his name.

Career Highlights

Darrell Yamashiro is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to develop and refine his innovative approaches to cancer treatment. His work has the potential to significantly impact the lives of patients battling severe forms of cancer.

Collaborations

Yamashiro collaborates with esteemed colleagues such as Jessica Kandel and Jocelyn Holash, contributing to a dynamic research environment focused on advancing cancer therapies.

Conclusion

Darrell Yamashiro's contributions to the field of oncology through his patented methods for tumor regression highlight his commitment to improving cancer treatment. His innovative work at Regeneron Pharmaceuticals, Inc. continues to pave the way for advancements in cancer care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…